Other
Concentrics Research
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
80%
4 trials in Phase 3/4
Results Transparency
100%
3 of 3 completed trials have results
Key Signals
2 recruiting3 with results
Enrollment Performance
Analytics
Phase 3
3(75.0%)
Phase 4
1(25.0%)
4Total
Phase 3(3)
Phase 4(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT07135323Recruiting
AvertD Post-Approval Study
Role: collaborator
NCT05310734Phase 4Recruiting
PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies
Role: collaborator
NCT04964544Phase 3Completed
Technology-Assisted Cholesterol Trial in Consumers (TACTiC)
Role: collaborator
NCT02485704Phase 3Completed
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Role: collaborator
NCT02485717Phase 3Completed
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Role: collaborator
All 5 trials loaded